17624-07-6 Usage
Uses
Used in Pharmaceutical Industry:
6-Mercaptonicotinic acid is used as an intermediate compound for the synthesis of various pharmaceuticals, due to its unique structure and reactivity.
Used in Medical Applications:
6-Mercaptonicotinic acid is used as a potential treatment for tuberculosis and other infectious diseases, as it has shown promise in preliminary studies.
Used in Anti-Inflammatory Applications:
6-Mercaptonicotinic acid is used as an anti-inflammatory agent, leveraging its potential to reduce inflammation and alleviate symptoms associated with inflammatory conditions.
Used in Antioxidant Applications:
6-Mercaptonicotinic acid is used as an antioxidant, helping to protect cells from damage caused by reactive oxygen species and contributing to overall health and wellness.
Used in Organic Chemistry Research:
6-Mercaptonicotinic acid is used as a research compound in the field of organic chemistry, where its properties and reactions are studied to gain insights into the development of new compounds and materials.
Check Digit Verification of cas no
The CAS Registry Mumber 17624-07-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,7,6,2 and 4 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 17624-07:
(7*1)+(6*7)+(5*6)+(4*2)+(3*4)+(2*0)+(1*7)=106
106 % 10 = 6
So 17624-07-6 is a valid CAS Registry Number.
InChI:InChI=1/C6H5NO2S/c8-6(9)4-1-2-5(10)7-3-4/h1-3H,(H,7,10)(H,8,9)
17624-07-6Relevant articles and documents
CRBN LIGANDS AND USES THEREOF
-
Paragraph 00473-00475, (2019/08/20)
The present invention provides compounds, compositions thereof, and methods of using the same for the inhibition of CRBN, and the treatment of CRBN-mediated disorders.
Tetracyclic benzimidazole derivatives and combinatorial libraries thereof
-
, (2008/06/13)
The present invention relates to novel tetracyclic benzimidazole derivative compounds of the following formula: wherein R1to R10have the meanings described in here. The invention further relates to combinatorial libraries containing two or more such compounds, as well as methods of preparing tetracyclic benzimidazole derivative compounds.
The reduction of specific disulfides with titanium(III) chloride
Akers, Hugh A.,Vang, Meng C.,Updike, Tracie D.
, p. 1364 - 1366 (2007/10/02)
The reaction between titanium(III) chloride and disulfides was investigated.Aryl and alkyl disulfides did not react while heterocyclic aromatic disulfides with a nitrogen α to the sulfur were reduced to the corresponding thiols.Products were identified and characterized by nuclear magnetic resonance and inrared spectra; and melting point comparisons with authentic compounds.The reductions occurred only in the presence of citrate and were found to require 2 moles of titanium(III) per mole of disulfide.